Johnson & Johnson
- JNJ
- NYSE
- Drug manufacturers
- Pharmaceuticals (Innovative Medicine)
- Medical Devices/MedTech
$253.63
Today −0.76%Quote Oct 19, 2026, 05:00 PM UTC
−5.43%over the last month
Max drawdown −8.6%From 1-month high −6.0%3 months +2.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
Where the money comes from
Q2 2026 revenue $25.31B
- Innovative Medicine$16.38B64.7%
- MedTech$8.93B35.3%
Sector
Healthcare
Industry
Drug manufacturers
Exchange
NYSE
Employees
141,700
Dividend date
Dec 8, 2026
Market value
$611.21B
Quote Oct 19
Floor
$247.63
2.4% below price
Resistance
$254.54
0.4% above price
Price vs analyst targets
40 analysts
Lowest target
$260.00Highest target
$320.00
$260.00Highest target
$320.00
- Price $253.63
- Average target $284.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 12% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about JNJPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free